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Abstract
Human T cell leukemia virus type I (HTLV-I) is the etiologic agent of adult T cell leukemia (ATL) and various inflam-
matory disorders including HTLV-I–associated myelopathy/tropical spastic paraparesis. HTLV-I oncoprotein Tax is
known to cause permanent activation of many cellular transcription factors including nuclear factor-κB (NF-κB), cyclic
adenosine 3′,5′-monophosphate response element–binding protein, and activator protein 1 (AP-1). Here, we show
that NF-κB–binding cofactor inhibitor of NF-κB-ζ (IκB-ζ) is constitutively expressed in HTLV-I–infected T cell lines
and ATL cells, and Tax transactivates the IκB-ζ gene, mainly through NF-κB. Microarray analysis of IκB-ζ–expressing
uninfected T cells demonstrated that IκB-ζ induced the expression of NF-κB– and interferon-regulatory genes such
as B cell CLL/lymphoma 3 (Bcl3), guanylate-binding protein 1, and signal transducer and activator of transcription 1.
The transcriptional activation domain, nuclear localization signal, and NF-κB–binding domain of IκB-ζ were required
for Bcl3 induction, and IκB-ζ synergistically enhanced Tax-induced Bcl3 transactivation in an NF-κB–dependent man-
ner. Interestingly, IκB-ζ inhibited Tax-induced NF-κB, AP-1 activation, and HTLV-I transcription. Furthermore, IκB-ζ inter-
actedwithTax in vitro and this interactionwas alsoobserved in anHTLV-I–transformedT cell line. These results suggest
that IκB-ζ modulates Tax-dependent and Tax-independent gene transcription in T cells. The function of IκB-ζ may be
of significance in ATL genesis and pathogenesis of HTLV-I–associated diseases.
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Introduction
Adult T cell leukemia (ATL) is a highly aggressive malignancy of CD4+
T cells caused by human T cell leukemia virus type I (HTLV-I) [1].
Infection with this retrovirus also results in inflammatory disorders
including HTLV-I–associated myelopathy/tropical spastic paraparesis
[2]. The majority of infected persons remain clinically asymptomatic,
whereas only 2% to 5% develop neoplasia after a latency of 40 to
60 years, which develops through genetic and epigenetic changes in
the cell [3]. However, the exact pathogenic mechanisms involved in
leukemogenesis remain obscure.
Tax, the viral oncoprotein, plays a central role in tumorigenesis and
contributes to the pathogenesis of ATL by inducing activation of many
cellular transcription factors including nuclear factor-κB (NF-κB),
cyclic adenosine 3′,5′-monophosphate response element–binding pro-
tein (CREB), and activator protein 1 (AP-1) [4]. Notably, NF-κB acti-
vation is essential for cellular transformation by HTLV-I [5]. Although
Tax is critical in the early stages of leukemogenesis, it also elicits a
strong cytotoxic T lymphocyte response resulting in rapid targeting of
Tax-expressing cells for their elimination. To escape from cytotoxic
T lymphocytes, Tax is not expressed in ATL cells, probably due to the
deletion or DNA methylation of a 5′ long terminal repeat (LTR) and
genetic changes in the tax gene, which inactivate its functions [3]. How-
ever, NF-κB is constitutively activated in primary ATL cells [6]. These
facts suggest activation of NF-κB in HTLV-I–infected T cells and
ATL cells in Tax-dependent and Tax-independent manners.
One of the inhibitor of NF-κB (IκB) family proteins, IκB-ζ, is an
inducible nuclear protein [7–9]. IκB-ζ is induced by proinflammatory
stimuli and lipopolysaccharide in NF-κB– and CREB-dependent
manners [10,11]. During inflammatory responses, IκB-ζ positively or
negatively regulates NF-κB–mediated transcription [12,13]. While
the inducible expression mechanisms and functions of IκB-ζ in the im-
mune system have been thoroughly investigated, the role of constitutive
expression of IκB-ζ in tumorigenesis and pathogenesis of various can-
cers, including ATL, remains elusive. In this study, we investigated
IκB-ζ expression in HTLV-I–infected T cells and ATL cells and the
mechanism for IκB-ζ gene transactivation by Tax. In addition, we
studied the roles played by inducible IκB-ζ as a means for regulating
Tax-dependent and Tax-independent cellular gene expression.
Materials and Methods
Cells
All the human T cell lines described previously [14–22] were
cultured in RPMI 1640 medium supplemented with 10% fetal calf
serum. 293T cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum. Peripheral blood
mononuclear cells (PBMCs) were isolated from healthy volunteers
and patients with ATL using Ficoll-Paque density gradient centri-
fugation (GE Healthcare, Piscataway, NJ). Informed consent was
obtained from all blood and tissue donors.
Antibodies and Reagents
Antibodies (Abs) to IκB-ζ for Western blot and immunohisto-
chemical analyses were purchased from Cell Signaling Technology
(Beverly, MA) and Novus Biologicals (Littleton, CO), respectively.
The following Abs were used for Western blot analysis: anti–B cell
CLL/lymphoma 3 (Bcl3; Bio Matrix Research Inc, Nagareyama,
Japan), anti–guanylate-binding protein 1 (GBP-1) to anti–GBP-5 (Santa
Cruz Biotechnology, Santa Cruz, CA), anti-actin, anti–retinoblastoma
protein (Rb; NeoMarkers, Fremont, CA), and anti-FLAG (Sigma-
Aldrich, St Louis, MO). Mouse monoclonal Ab to Tax, Lt-4 [23],
was used for Western blot analysis and immunoprecipitation. Abs to
p50, RelA, c-Rel, p52, and RelB for electrophoretic mobility shift assay
(EMSA) were purchased from Santa Cruz Biotechnology. Bay 11-7082
and N -acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) were purchased
from Calbiochem (La Jolla, CA) and Sigma-Aldrich, respectively.
Reverse Transcription–Polymerase Chain Reaction
Reverse transcription–polymerase chain reaction (RT-PCR) was
carried out as described previously [24]. The sequences of the primers
for IκB-ζ, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [25],
interleukin-2 receptor α chain (IL-2Rα) [26], Bcl3 [27], GBP-1 [28],
signal transducer and activator of transcription 1 (STAT1) [29], SLAM
family member 7 (SLAMF7) [30], Tax in HTLV-I–infected T cell
lines and ATL cells [25], and Tax in JPX-9 cells [25] are summarized
in Table 1. PCR was halted during the exponential phase of DNA
amplification, and the reaction products were fractionated on agarose
gels and visualized by ethidium bromide staining. The obtained bands
of amplified DNA were quantified using ImageJ.
Plasmids
pGL3-basic and phRL-TK were purchased from Promega (Madison,
WI). pGL3–hIκB-ζ (−11 kb) and pGL3–hIκB-ζ (−853) were described
previously [10]. pGL3–hIκB-ζ (−853) κB1D, κB2D, and κB1/κB2D
were prepared from pGL3–hIκB-ζ (−853). Bcl3, GBP-1, and STAT1
luciferase reporter constructs were described previously [31–33].
IL-8 −133-Luc [34], pGL3–inducible nitric oxide synthase (iNOS)
[35], NF-κB–Luc [36], AP-1–Luc [34], and HTLV-I LTR-Luc [37]
were used for reporter assay. Expression vectors for Tax and its mu-
tants and the dominant negative mutants of IκBα, IκBβ, IκB kinase 1
(IKK1; IKKα), IKK2 (IKKβ), NEMO (IKKγ), and NF-κB–inducing
kinase (NIK) were described previously [38–42]. The dominant
Table 1. Primer Sequences.
Gene Name Forward Sequence Reverse Sequence
Human IκB-ζ 5′-GGAGCTTTTACTGAAGAATAAGA-3′ 5′-ATCTGTTCTCCCACAGGGCCATC-3′
Human GAPDH 5′-GCCAAGGTCATCCATGACAACTTTGG-3′ 5′-GCCTGCTTCACCACCTTCTTGATGTC-3′
Human IL-2Rα 5′-ATCCCACACGCCACATTCAAAGC-3′ 5′-TGCCCCACCACGAAATGATAAAT-3′
Human Bcl3 5′-CCACAGACGGTAATGTGGTG-3′ 5′-TATTGCTGTGGTGCAGGGTA-3′
Human GBP-1 5′-GGTCCAGTTGCTGAAAGAGC-3′ 5′-TGACAGGAAGGCTCTGGTCT-3′
Human STAT1 5′-AAGGTGGCAGGATGTCTCAGT-3′ 5′-TGGTCTCGTGTTCTTCTGTTCTG-3′
Human SLAMF7 5′-GTCTCTTTGTACTGGGGCTATTTC-3′ 5′-TTTTCCATCTTTTTCGGTATTT-3′
Tax in HTLV-I–infected T cell lines and primary ATL cells 5′-CCGGCGCTGCTCTCATCCCGGT-3′ 5′-GGCCGAACATAGTCCCCCAGAG-3′
Tax in JPX-9 cells 5′-ATCGGCTCAGCTCTACAGTTCCT-3′ 5′-ATTCGCTTGTAGGGAACATTGGT-3′
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negative mutants of CREB and pcDNA3 were purchased from
Clontech Laboratories (Mountain View, CA) and Invitrogen (Carlsbad,
CA), respectively.
pcDNA3-HBZ-Myc, pcDNA3-RelA, and various mouse IκB-ζ–
expressing vectors were described previously [13,43,44]. pCS-puro-
EGFP, pCS-puro-Zeta#1, pCS-puro-Zeta#2, pCAG-HIVgp, and
pCMV-VSV-G-RSV-Rev were used for IκB-ζ knockdown by lentiviral
induction. Oligonucleotides containing the targeting pSR-enhanced green
fluorescent protein (EGFP) (5′-GCAGCACGACTTCTTCAAG-3′) and
human IκB-ζ No. 1 (5′-GACACCACCTCAAACACCA-3′) and No. 2
(5′-GACCAGGCTTCCCTGTACC-3′) were inserted into the pSUPER.
retro.puro vector (Oligoengine, Seattle, WA), generating pSR-enhanced
green fluorescent protein (EGFP), pSR-Zeta#1, and pSR-Zeta#2, respec-
tively. The short hairpin RNA (shRNA) expression cassettes were then
transferred to a lentiviral vector, pCS-puro-PRE [45]. Lentiviral vec-
tors expressing shRNA were constructed by inserting a fragment of
pSR-EGFP, Zeta#1, and Zeta#2 into pCS-puro-PRE, denoted as pCS-
puro-EGFP, Zeta#1, and Zeta#2, respectively. The Escherichia coli expres-
sion vectors pGEX 4T-2 and pGEX 4T-2-Tax [46] were used for the
purification of glutathione S-transferase (GST) andGST-Tax, respectively.
Electrophoretic Mobility Shift Assay
Nuclear extracts (NEs) from cells were prepared, and EMSA was
performed as described previously [24]. The DNA sequences of
probes and competitors are summarized in Table 2.
Immunohistochemical Analysis
Biopsy samples were taken from the lymph nodes of six patients
with ATL and also from two specimens of normal lymph nodes.
Immunohistochemical staining was performed using anti–IκB-ζ after
pretreatment of the deparaffinized tissue sections with ready-to-use
proteinase K (Dako, Carpinteria, CA). The sections were counter-
stained with methyl green, and the stained cells were examined under
a light microscope.
Luciferase Assay
Cells were transfected with the appropriate reporter and effector
plasmids by electroporation using Gene Pulser (Bio-Rad, Hercules,
CA). After 24 hours, luciferase assays were performed with the Dual
Luciferase Assay System (Promega). Luciferase activities were normalized
relative to the Renilla luciferase activity from cotransfected phRL-TK.
Western Blot Analysis and Coomassie Brilliant Blue Staining
Western blot analysis was performed using a standard protocol [24].
As loading control, expression of actin and Rbs was included. The
bands were prepared with Coomassie brilliant blue (CBB) staining.
Microarray Analysis
RNA was extracted using an RNeasy Plus Mini Kit (Qiagen,
Hilden, Germany). Microarray analysis using a Human 1A Oligo
Microarray Kit V2 (Agilent Technologies, Santa Clara, CA) was
performed as described previously [24].
IκB-ζ Knockdown
The procedure of gene knockdown by lentiviral induction was
described previously [45]. Viral supernatants were generated by trans-
fecting 293T cells with pCS-puro-EGFP, pCS-puro-Zeta#1, or
pCS-puro-Zeta#2 together with the pCAG-HIVgp and pCMV-
VSV-G-RSV-Rev using FuGENE HD (Promega).
Immunoprecipitation and GST Pull-Down Assay
293T cells were cotransfected with various expression plasmids
for IκB-ζ and/or pHβ-Tax using FuGENE HD. In the immuno-
precipitation assay, anti-Tax Ab and Protein G Sepharose 4 Fast Flow
(GE Healthcare) were used. For GST pull-down assay, 293T cells were
lysed in lysis buffer, and whole-cell extracts (WCEs) were incubated
with glutathione sepharose 4B (GE Healthcare)–conjugated GST or
GST-Tax proteins purified from isopropyl thiogalactoside–induced
E coli JM109 transformed with pGEX 4T-2 or pGEX 4T-2–Tax [46].
Statistical Analysis
Differences between groups were examined for statistical significance
using the unpaired Student’s t test. P values less than .05 denoted the
presence of a statistically significant difference.
Results
Constitutive Expression of IκB-ζ in HTLV-I–Infected
T Cells and ATL Cells
RT-PCR identified marked expression of IκB-ζ in Tax-expressing
HTLV-I–transformed T cell lines, MT-2, MT-4, C5/MJ, SLB-1, and
HUT-102, compared with uninfected T cell lines, Jurkat, Molt-4, and
CCRF-CEM (Figure 1A). IκB-ζ was also weakly expressed in ATL-
derived T cell lines, MT-1, TL-OmI, and ED-40515(−). IκB-ζ,
a known nuclear protein (Figure 1B), was also highly expressed in
the nuclei of HTLV-I–transformed T cell lines, MT-2, SLB-1,
HUT-102, and MT-4. RT-PCR showed high expression of IκB-ζ in
PBMCs from patients with ATL compared with those from healthy
donors (Figure 1C ). In addition, immunohistochemical staining
identified IκB-ζ–positive ATL cells in the nuclei of lymph nodes
obtained from all six patients with ATL (Figure 1D). These data sug-
gest that IκB-ζ is constitutively expressed in HTLV-I–infected T cells
and ATL cells.
Tax Transactivates the IκB-ζ Promoter Mainly through the
NF-κB Pathway
To study the effect of Tax on IκB-ζ gene expression at the trans-
criptional level, we performed luciferase assays in Jurkat cells using
reporter plasmids for IκB-ζ. Tax markedly activated both reporter plas-
mids, IκB-ζ (−11 kb) and IκB-ζ (−853), in a dose-dependent manner
(Figure 2A). HBZ, another viral regulatory protein, showed no effect
on the activation of the IκB-ζ promoter in contrast to Tax (Figure 2B).
To narrow down the transactivation-relevant signaling pathways, Tax
M22 and 703 mutants [38] were cotransfected along with the IκB-ζ
promoter construct, followed by determination of luciferase activities
(Figure 2C ). Tax M22 mutant, defective in NF-κB activation, failed
Table 2. DNA Sequences of Probes and Competitors.
Name of Oligonucleotide Top Strand Sequence
IκB-ζ WT κB1 5′-GATCCGACGGGAATGTCCGGGACT-3′
IκB-ζ WT κB2 5′-GATCGGTCTGGGAATTTCCAGTG-3′
IκB-ζ κB1 mutant 5′-GATCCGACGtGtATGaCCGGGACT-3′
IκB-ζ κB2 mutant 5′-GATCGGTCTGtGtATaaCCAGTG-3′
IL-2Rα κB 5′-GATCCGGCAGGGGAATCTCCCTCTC-3′
IL-8 AP-1 5′-GATCGTGATGACTCAGGTT-3′
Oct-1 5′-GATCTGTCGAATGCAAATCACTAGAA-3′
The underlined sequences are the NF-κB–, AP-1–, and Oct-1–binding sites, respectively. The sites
of mutation are indicated in lowercase.
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to activate the IκB-ζ promoter. In contrast, Tax 703 mutant, which can
activate NF-κB but not CREB, slightly activated the IκB-ζ promoter,
but the level was less than wild-type (WT) Tax. However, Tax M22
and 703 mutants together activated the IκB-ζ promoter as observed
with WT Tax expression. These results suggest that Tax activates the
IκB-ζ promoter in NF-κB– and CREB-dependent manners. Next,
we examined whether Tax-mediated transactivation of the IκB-ζ
gene requires the signal transduction components involved in NF-κB
activation. The dominant interfering mutants of IκBα, IκBβ, and
NEMO and kinase-deficient mutants of IKK1, IKK2, and NIK were
tested for their ability to inhibit Tax-mediated transactivation of IκB-ζ
reporter gene activity. The expression of these mutants, especially
IκBα, IκBβ, and IKK1 inhibitory mutants, significantly inhibited
Tax-induced activation of the IκB-ζ promoter (Figure 2D), suggesting
that signaling components involved in the activation of NF-κB are
necessary for Tax-mediated transactivation of IκB-ζ promoter. In
addition, we tested the potential role of CREB in modulating Tax-
induced IκB-ζ promoter activity. For this purpose, the dominant
negative CREB mutants, KCREB and CREB133, were transfected
with IκB-ζ promoter construct as well as an expression vector for
Tax. KCREB contains mutations in its DNA-binding domain [47].
CREB133 contains a serine-to-alanine mutation corresponding to
amino acid 133, and this mutation blocks CREB phosphorylation,
thus preventing transcription [47]. Overexpression of CREB133, but
not KCREB, inhibited the IκB-ζ promoter activity in response to Tax
by about 50% (Figure 2E), suggesting that CREB phosphorylation is
partially required for Tax-mediated IκB-ζ promoter activation.
The human IκB-ζ promoter (position, −853 to −17) contains two
NF-κB–binding sequences [10], κB1 and κB2 sites (Figure 2F). A sin-
gle deletion of the κB2 site from the IκB-ζ reporter plasmid markedly
inhibited either Tax- or RelA-induced transactivation, whereas a single
deletion of the κB1 site resulted in moderate activation (Figure 2F).
Figure 1. Constitutive expression of IκB-ζ in HTLV-I–infected T cell lines and primary ATL cells. (A) Expression of IκB-ζ and Tax mRNA in
HTLV-I–infected T cell lines. RT-PCR analysis was carried out for IκB-ζ, Tax, and GAPDH (loading control). (B) Expression of IκB-ζ in NEs
from HTLV-I–infected T cell lines. Western blot analysis for IκB-ζwas performed by immunoblot analysis with anti–IκB-ζ Ab. CBB stainingwas
carried out for loading control. (C) RT-PCR analysis for IκB-ζ, Tax, and GAPDH expression in PBMCs from healthy donors and patients with
ATL. IκB-ζ/GAPDH ratios were calculated by densitometric analysis of the bands. Data on the right are means ± SD of ratios (***P < .001).
(D) Immunohistochemical staining for IκB-ζ in ATL lymph nodes. Tissue sections from ATL lymph nodes and normal lymph nodes were
stained with anti–IκB-ζ Ab. Representative results from two patients with ATL and one normal lymph node. Original magnification, ×400.
Neoplasia Vol. 15, No. 9, 2013 IκB-ζ Modulates Gene Expression in T Cells Kimura et al. 1113
Double deletions completely abolished the Tax- and RelA-induced
transactivation. These results suggest that both NF-κB–binding sites
in the promoter are essential for the complete transcriptional activation
of the IκB-ζ gene.
NF-κB–Binding Activity in the Two NF-κB–Binding Sites
of the IκB-ζ Promoter
In the next step, we identified the transcription factors that bind
to the κB1 and κB2 elements in the IκB-ζ promoter. EMSA was per-
formed with oligonucleotides representing the κB1 and κB2 elements.
Protein complexes binding to the κB2 sites were detected using NEs
derived from HTLV-I–transformed T cell lines and ATL-derived
T cell lines compared with uninfected T cell lines, although the
levels of binding activities with ATL-derived T cell lines were less than
those with transformed T cell lines (Figure 3A). In addition, protein
complexes binding to the κB1 sites were detected with NEs derived
from transformed T cell lines.
The specificity of DNA-protein complex formation was assessed by
competition studies with unlabeled competitors. As expected, “cold”
(unlabeled) IκB-ζ WT κB2 and κB1 oligonucleotides or one based
Figure 2. Tax transactivates the IκB-ζ promoter mainly through the NF-κB pathway. (A) Jurkat cells were transfected with the indicated
IκB-ζ promoter fragments cloned into pGL3-basic together with various amounts of pHβ-Tax. Cells were harvested 24 hours post-
transfection, and luciferase activity was measured. The activities are expressed relative to that of cells transfected with pGL3-basic alone,
which was defined as 1. (B) Cells were transfected with pGL3–IκB-ζ (−853) together with empty vector, pcDNA3.1-HBZ-Myc, or pHβ-Tax.
The results are expressed as fold induction by Tax or HBZ relative to the vector alone. (C) Cells were transfected with pGL3–IκB-ζ (−853)
together with pHβ empty vector, pHβ–wild-type Tax (WT), Tax M22 mutant, Tax 703 mutant alone, or the combination of Tax M22 and Tax
703 mutants. The results are expressed as fold induction by Tax or Tax mutants relative to the vector alone. (D and E) Cells were transfected
with pGL3–IκB-ζ (−853) together with pHβ-Tax and the indicated dominant negative mutants or empty vector. DN, dominant negative. The
results are expressed as fold induction by Tax relative to the vector alone. (F) Cells were transfected with the indicated IκB-ζ reporter
constructs together with pHβ-Tax, pcDNA3-RelA, or empty vector. The activities are expressed relative to that of cells transfected with
pGL3–IκB-ζ (−853) and empty vector, which was defined as 1. The internal control reporter phRL-TK was cotransfected in all experiments.
Data are means ± SD of three independent transfection experiments.
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Figure 3. NF-κB subunits bound to two NF-κB–binding sites of the IκB-ζ promoter are essential for the Tax-induced IκB-ζ gene expression.
(A) EMSA with the κB2- and κB1-binding sites of the IκB-ζ promoter in NEs from T cell lines. NEs from T cell lines were incubated with the
indicated probes. Oct-1 regulates the transcription of a number of housekeeping genes. (B and C) Supershift assay and competition analysis
with the κB2- and κB1-binding sites in T cell lines. NEs from HUT-102, ED-40515(−), and Jurkat cells were treated with the indicated Abs
and incubated with κB2- or κB1-binding site probe in the absence or presence of the unlabeled oligonucleotides representing the IκB-ζWT
κB2 site, an IκB-ζ κB2 mutant site, the IκB-ζ WT κB1 site, an IκB-ζ κB1 mutant site, an NF-κB site from the IL-2Rα promoter (IL-2R κB), or
an AP-1 site from the IL-8 promoter (IL-8 AP-1). Arrowhead, the DNA-binding complex supershifted by Ab. (D) Expression of IκB-ζ and Tax
mRNA in CdCl2-treated JPX-9 cells. JPX-9 cells were treated with CdCl2 for the indicated time periods. RT-PCR analysis was carried out
for IκB-ζ, Tax, and GAPDH (loading control). (E) Jurkat or JPX-9 cells were treated with or without CdCl2 for 24 hours. RT-PCR analysis
was carried out for IκB-ζ, IL-2Rα, Tax, and GAPDH (loading control). (F) EMSA with the κB2- and κB1-binding sites of the IκB-ζ promoter
in NEs from CdCl2-treated JPX-9 cells. Cells were treated with CdCl2 for the indicated time periods. NEs were incubated with the indicated
probes. *Nonspecific band. (G and H) Supershift assay and competition analysis with the κB2- and κB1-binding sites of the IκB-ζ promoter
in CdCl2-treated JPX-9 cells. Cells were treated with CdCl2 for 96 hours. NEs from untreated (G, right) and CdCl2-treated JPX-9 cells (G, left
and H) were treated with the indicated Ab and incubated with κB2- or κB1-binding site probe in the absence or presence of the unlabeled
indicated oligonucleotides. Arrowhead, the DNA-binding complex supershifted by Ab. (I) HUT-102 cells were treated with NF-κB inhibitors,
Bay or LLnL (0, 5, 10, or 20 μM), for 24 hours. RT-PCR analysis was carried out for IκB-ζ, Tax, and GAPDH (loading control). (J) Expression
of IκB-ζ protein in NEs from Bay- or LLnL-treated HUT-102 cells. Western blot analysis for IκB-ζ was performed by immunoblot analysis
with anti–IκB-ζ Ab. CBB staining was carried out for loading control. (K) EMSA with the κB2- and κB1-binding sites of the IκB-ζ promoter
in NEs from Bay- or LLnL-treated HUT-102 cells. NEs were incubated with the indicated probes. (L) JPX-9 cells were pretreated with either
Bay or LLnL (0, 5, 10, or 20 μM) for 1 hour before treatment with CdCl2 for another 24 hours. RT-PCR analysis was carried out for IκB-ζ and
GAPDH (loading control).
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on the NF-κB site from the IL-2Rα promoter all efficiently competed
with the labeled κB2 probe and eliminated the binding of NEs from
HUT-102 and ED-40515(−) cells (Figure 3B). In addition, the un-
labeled IκB-ζ κB1 and κB2 oligonucleotides or NF-κB site from the
IL-2Rα promoter effectively competed with the labeled κB1 probe and
eliminated the binding of NEs from HUT-102 cells (Figure 3C ). In
contrast, the unlabeled IκB-ζ κB2 and κB1 mutants or consensus
AP-1 site from the IL-8 promoter could not compete with the labeled
κB2 and κB1 probes (Figure 3, B and C ). The composition of the
transcription factor DNA-protein complexes in HUT-102 and ED-
40515(−) cells was analyzed by supershift assay using specific Abs (Fig-
ure 3, B and C). These experiments indicated that the complexes κB2
and κB1 in HUT-102 corresponded to p50, RelA, c-Rel, and p52,
and the complexes κB1 in ED-40515(−) corresponded to p50, RelA,
c-Rel, and RelB. In contrast, DNA-protein complexes to the IκB-ζ
κB2 site in Jurkat cells were not supershifted by any of the NF-κB sub-
unit Abs, suggesting that protein complexes to the κB2 site detected in
Jurkat cells do not consist of NF-κB proteins (Figure 3B, bottom). These
results suggest that NF-κB components are bound to the κB1 and κB2
sites of the IκB-ζ promoter in HTLV-I–transformed T cell lines and to
the κB1 site alone in ATL-derived T cell lines, respectively.
Tax Induces IκB-ζ Gene Expression through NF-κB Activation
Treatment of JPX-9 cells, a Jurkat subline that carries the tax gene
under the control of the metallothionein gene promoter [14], with
CdCl2 rapidly induced Tax mRNA expression (Figure 3D). IκB-ζ
mRNA was also induced by 24 hours after treatment with CdCl2
(Figure 3D). In contrast, the same treatment did not induce Tax, IL-2Rα,
and IκB-ζ mRNA expression in Jurkat cells (Figure 3E). In addition,
EMSA analysis of NEs from the CdCl2-treated JPX-9 cells showed that
Tax expression alone elicited binding to the IκB-ζ κB2 and κB1 probes
(Figure 3F ). The unlabeled IκB-ζ κB2 and κB1 oligonucleotides or
an NF-κB site from the IL-2Rα promoter effectively competed with
the labeled κB2 and κB1 probes and eliminated the binding of NEs
from CdCl2-treated JPX-9 cells [Figure 3, G (left) and H]. In contrast,
the unlabeled IκB-ζ κB2 and κB1 mutants or consensus AP-1 site
could not compete with the labeled probes [Figure 3, G (left) and H].
Supershift assay demonstrated that complex κB2 corresponded to p50,
RelA, and RelB, and complex κB1 corresponded to p50, RelA, and
c-Rel [Figure 3, G (left) and H ]. In contrast, the protein complexes
bound to the κB2 oligonucleotide in untreated JPX-9 cells were not
supershifted by any of the NF-κB subunit Abs (Figure 3G , right). These
data suggest that Tax induces expression by activating the binding of
NF-κB proteins to two NF-κB sites in the IκB-ζ gene promoter.
To determine the other roles of NF-κB in IκB-ζ expression, we
used NF-κB signaling inhibitors. Both Bay 11-7082, an inhibitor of
IκBα phosphorylation [48], and LLnL, a proteasomal inhibitor [49],
inhibited the expression of IκB-ζ at the mRNA (Figure 3I ) and pro-
tein (Figure 3J) levels and NF-κB binding to the IκB-ζ κB2 and κB1
probes in HUT-102 cells (Figure 3K ). Both inhibitors suppressed
the Tax-induced expression of IκB-ζ mRNA in CdCl2-treated JPX-9
cells (Figure 3L). These findings indicate that the Tax-induced IκB-ζ
expression is mediated mainly through the activation of NF-κB.
IκB-ζ Induces Bcl3 Gene Expression in an
NF-κB–Dependent Manner
To analyze IκB-ζ–induced gene expression in T cells, we compared
the gene expression profiles by cDNA microarray analysis using RNA
isolated from Jurkat cells transfected with IκB-ζ or a control vector.
In IκB-ζ–expressing Jurkat cells, 19 genes were upregulated (five-fold
or greater) compared with control Jurkat cells (Table 3). One member
of the IκB family, Bcl3, is known to be an NF-κB–regulatory gene
similar to IκB-ζ [31]. In addition, the following genes are all inter-
feron (IFN)–stimulated genes (ISGs): GBP-1 [32]; GBP-2; GBP-5;
STAT1 [33]; NLR family, CARD domain containing 5; epithelial
stromal interaction 1 (breast); 4-aminobutyrate aminotransferase; trans-
porter 1, ATP-binding cassette, subfamily B; regulator of G protein sig-
naling 9; interferon-induced protein with tetratricopeptide repeats 3;
interferon-induced protein 44-like; poly(ADP-ribose) polymerase family,
member 9; Kelch domain containing 7B; interferon, α-inducible pro-
tein 27. These results suggest that IκB-ζ induces the expression of
NF-κB– and IFN-regulatory genes in T cells. Next, we analyzed the
levels of some of these specific mRNAs by RT-PCR. IκB-ζ dose-
dependently induced Bcl3, GBP-1, STAT1, and SLAMF7 gene
expression in Jurkat cells (Figure 4A).
To determine the effects of IκB-ζ on Bcl3 gene expression at the
transcriptional level, we performed luciferase reporter assays using
Bcl3 promoter/enhancer–luciferase reporter plasmids [31]. IκB-ζ
dose-dependently activated Bcl3 expression through the promoter
region together with the intronic enhancer region 3 (Pr11 E3) in
Jurkat cells (Figure 4B). Bcl3 E3 contains one NF-κB–binding se-
quence (Figure 4C), and IκB-ζ only modestly activated Bcl3 expres-
sion through the upstream promoter (Pr11) or the promoter region
together with enhancer region 4 (Pr11 E4). IκB-ζ also activated Bcl3
transcription through the promoter containing both E3 and E4 (Pr11
E3 + E4; Figure 4C ). To further confirm that the NF-κB pathway
was responsible for IκB-ζ–induced expression of Bcl3, we tested a
Bcl3 reporter construct carrying a mutation in the NF-κB site. Fig-
ure 4C shows that the NF-κB site in E3 is the primary element re-
sponsible for IκB-ζ induction of the Bcl3 gene. However, previous
studies have shown that Tax mediates Bcl3 induction through
an intronic enhancer [50] and Bcl3 is constitutively expressed in
HTLV-I–infected T cells [51]. For this reason, we investigated the
synergistic effect of Tax and IκB-ζ on Bcl3 transactivation. Bcl3
Pr11 E3 responded to Tax and RelA, but Bcl3 Pr11 E3ΔκB reduced
Table 3. Genes Upregulated by IκB-ζ (Fold Change ≥ 5.0).
Gene Name Gene Symbol Accession No. Fold Change
SLAM family member 7 SLAMF7 NM_021181 20.8
Guanylate-binding protein 1 GBP-1 NM_002053 12.1
Guanylate-binding protein 2 GBP-2 NM_004120 9.6
B cell CLL/lymphoma 3 Bcl3 NM_005178 9.3
NLR family, CARD domain containing 5 NLRC5 NM_032206 8.0
Guanylate-binding protein 5 GBP-5 NM_052942 8.0
Epithelial stromal interaction 1 (breast) EPSTI1 NM_033255 8.0
Signal transducer and activator of
transcription 1
STAT1 NM_139266 7.8
4-Aminobutyrate aminotransferase ABAT NM_000663 7.2
G protein–coupled receptor 18 GPR18 NM_005292 7.0
Transporter 1, ATP-binding cassette,
subfamily B
TAP1 NM_000593 6.8
Regulator of G protein signaling 9 RGS9 NM_003835 6.8
Interferon-induced protein with
tetratricopeptide repeats 3
IFIT3 NM_001549 6.5
Interferon-induced protein 44-like IFI44L NM_006820 6.4
Poly(ADP-ribose) polymerase family,
member 9
PARP9 NM_031458 5.5
Tubulin polymerization promoting protein TPPP NM_007030 5.5
Interleukin-4–induced 1 IL-4I1 NM_172374 5.3
Kelch domain containing 7B KLHDC7B NM_138433 5.0
Interferon, α-inducible protein 27 IFI27 NM_005532 5.0
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Figure 4. IκB-ζ and Tax activate Bcl3 gene expression in an NF-κB–dependent manner. (A) Gene expression in IκB-ζ–expressing Jurkat
cells. Cells were transfected with various amounts of pcDNA3–FLAG–IκB-ζ. Cells were harvested 24 hours post-transfection, and RT-PCR
analysis was carried out for Bcl3, GBP-1, STAT1, SLAMF7, and GAPDH (loading control). (B) Jurkat cells were transfected with a luciferase
reporter containing the Bcl3 promoter in combinationwith enhancer E3 (pGL3–Bcl3 Pr11 E3) together with the various amounts of pcDNA3–
FLAG–IκB-ζ. Luciferase activity was measured 24 hours after transfection, and the results are expressed as fold induction by IκB-ζ relative
to the vector alone. (C) Cells were transfected with the indicated reporter constructs containing the Bcl3 promoter either alone or in com-
bination with enhancers E3, E4, and E3/E4 together with pcDNA3–FLAG–IκB-ζ or empty vector. The activities are expressed relative to that
of cells transfected with pGL3-basic and empty vector, which was defined as 1. (D) Cells were transfected with pGL3–Bcl3 Pr11 E3 or
pGL3–Bcl3 Pr11 E3ΔκB together with empty vector, pHβ-Tax, or pcDNA3-RelA. The activities are expressed relative to that of cells trans-
fected with pGL3–Bcl3 Pr11 E3 and empty vector, which was defined as 1. (E) Cells were transfected with pGL3–Bcl3 Pr11 E3 or pGL3–Bcl3
Pr11 E3ΔκB together with the various amounts of pcDNA3–FLAG–IκB-ζ in the absence or presence of pHβ-Tax or pcDNA3-RelA. The
activities are expressed relative to that of cells transfected with pGL3–Bcl3 Pr11 E3 and empty vector, which was defined as 1.
(F) Schematic diagrams of WT IκB-ζ and IκB-ζ deletion mutants containing IκB-ζ amino acids 1 to 456, 153 to 728, 188 to 728, and
457 to 728. (G) Jurkat cells were transfected with pGL3–Bcl3 Pr11 E3 together with empty vector, pcDNA3–FLAG–WT IκB-ζ, or IκB-ζ dele-
tion mutants. The results are expressed as fold induction by WT IκB-ζ or IκB-ζmutants. (H) Cells were transfected with pGL3–Bcl3 Pr11 E3
with WT IκB-ζ or IκB-ζmutants in the absence or presence of pHβ-Tax or pcDNA3-RelA. The activities are expressed relative to that of cells
transfected with pGL3–Bcl3 Pr11 E3 and empty vector, which was defined as 1. The internal control reporter phRL-TK was cotransfected in
all experiments. Data are means ± SD of three independent transfection experiments. (I) Expression of Bcl3 in NEs from IκB-ζ knockdown
HUT-102 and SLB-1 cells. Western blot analysis for Bcl3, IκB-ζ, Tax, and Rb (loading control) was performed by immunoblot analysis.
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the response to Tax and RelA (Figure 4D). In addition, IκB-ζ dose-
dependently enhanced Tax- and RelA-induced Bcl3 Pr11 E3 activa-
tion, but it was not observed in Bcl3 Pr11 E3ΔκB (Figure 4E). These
results suggest that IκB-ζ synergistically enhances Tax- and RelA-
induced Bcl3 transactivation in an NF-κB–dependent manner.
Next, we investigated the domains of IκB-ζ required for Bcl3 trans-
activation. IκB-ζ is separable into two parts, amino (N)–terminal and
carboxyl-terminal regions (Figure 4F) [7]. The N-terminal region of
IκB-ζ contains a nuclear localization signal (NLS) and a transcriptional
activation domain (TAD). The carboxyl-terminal region of IκB-ζ
harbors the ankyrin repeats, which are responsible for NF-κB bind-
ing. We used full-length WT IκB-ζ– and IκB-ζ deletion mutant–
expressing vectors containing IκB-ζ amino acids 1 to 456, 153 to
728, 188 to 728, and 457 to 728 (Figure 4F ). The deletion mutants
of IκB-ζ amino acids 1 to 456, 188 to 728, and 457 to 728 did not
activate Bcl3 Pr11 E3, while WT IκB-ζ and the deletion mutant of
IκB-ζ amino acids 153 to 728 induced Bcl3 Pr11 E3 transactivation
(Figure 4G ). In addition, WT IκB-ζ and IκB-ζ amino acids 153
to 728, but not 1 to 456, 188 to 728, and 457 to 728, enhanced
Tax- and RelA-induced Bcl3 transcription (Figure 4H). These results
highlight the importance of the TAD-, NLS-, and NF-κB–binding
domains of IκB-ζ in Bcl3 transactivation.
To investigate the role of IκB-ζ in Bcl3 expression in HTLV-I–
infected T cells, we performed knockdown of IκB-ζ in HUT-102
and SLB-1 cells using IκB-ζ shRNA (Figure 4I ). Silencing IκB-ζ
expression decreased Bcl3 expression but did not affect Tax expres-
sion levels in these cells.
IκB-ζ Induces Expression of IFN-Regulatory Genes, GBP-1,
and STAT1
The genes upregulated by IκB-ζ included several IFN-regulatory
genes. Therefore, we investigated the effect of IκB-ζ on the expression
of two of these, GBP-1 and STAT1 genes at the transcriptional level.
First, we performed luciferase reporter assays using several GBP-1
luciferase reporter plasmids. IκB-ζ, but not Tax, activated Pro3757–
GBP-1 (position, −1778 to +1979), Pro1762–GBP-1 (−1778 to −17),
and Pro237–GBP-1 (−218 to +19), indicating that Pro237–GBP-1 is
sufficient to mediate GBP-1 expression in response to IκB-ζ (Fig-
ure 5A). Previous studies showed that the NF-κB motif and IFN-α–
stimulated response element (ISRE) cooperate in the activation of
GBP-1 expression by inflammatory cytokines [32]. To determine the
role of the NF-κB and ISRE sites on GBP-1 expression induced by
IκB-ζ, single or double mutants of the respective sites were used.
IκB-ζ could not transactivate Pro237–GBP-1 ΔISRE or Pro237–
GBP-1 ΔISRE/cRel mutants but activated the Pro237–GBP-1 ΔcRel
mutant (Figure 5A). These data suggest that IκB-ζ induces GBP-1 tran-
scription in an ISRE-dependent manner. We also investigated the role
of IκB-ζ in GBP-1 expression in HTLV-I–infected T cells. Depletion
Figure 5. IκB-ζ activates GBP-1 and STAT1 gene transcription. (A) Jurkat cells were transfected with the indicated GBP-1 reporter con-
structs together with empty vector, pcDNA3–FLAG–IκB-ζ, or pHβ-Tax. The activities are expressed relative to that of cells transfected
with pGL3-basic and empty vector, whichwas defined as 1. (B) Expression of GBP-1 inWCEs from IκB-ζ knockdown HUT-102 cells. Western
blot analysis for GBP-1 to GBP-5 and actin (loading control) was performed by immunoblot analysis. (C) Jurkat cells were transfected with
pGL3-basic or STAT1 promoter/enhancer reporter construct together with empty vector or various amounts of pcDNA3–FLAG–IκB-ζ. The
activities are expressed relative to that of cells transfected with pGL3-basic and empty vector, which was defined as 1. (D) Cells were
transfected with STAT1 promoter/enhancer reporter construct together with empty vector, pcDNA3–FLAG–IκB-ζ, or pHβ-Tax. Cells were
harvested 24 hours post-transfection, and luciferase activity was measured. The results are expressed as fold induction by IκB-ζ or Tax
relative to the vector alone. The internal control reporter phRL-TK was cotransfected in all experiments. Data are means ± SD of three
independent transfection experiments.
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of IκB-ζ decreased GBP-1 to GBP-5 expression in HUT-102 cells
(Figure 5B).
Next, we studied the effect of IκB-ζ on STAT1 gene expression at
the transcriptional level by luciferase assays using STAT1 promoter/
enhancer–luciferase reporter plasmid (position, −338 to +1033).
IκB-ζ dose-dependently induced STAT1 promoter/enhancer activa-
tion in Jurkat cells (Figure 5C ). In addition, Tax transactivated the
STAT1 promoter/enhancer similar to IκB-ζ. These data suggest that
IκB-ζ and Tax induce STAT1 transactivation in T cells.
IκB-ζ Modulates Tax-Induced Gene Transactivation
IκB-ζ is known as a positive and negative regulator of NF-κB–
mediated transcription [7,12,13]. Therefore, we investigated the effect
of IκB-ζ on the expression of several genes known to be induced by
either Tax or NF-κB. For example, previous studies showed that the
promoters of IL-8 [52] and iNOS genes [53] contain NF-κB–binding
sequences and are also regulated by Tax and NF-κB [52–54]. IκB-ζ
dose-dependently inhibited Tax-induced activation of IκB-ζ (−853;
Figure 6A) and IL-8 −133 (Figure 6B) reporter plasmids in Jurkat
cells, while IκB-ζ alone did not affect the activation of these reporter
plasmids. In contrast, IκB-ζ dose-dependently activated the iNOS
promoter and enhanced Tax-induced iNOS promoter activation (Fig-
ure 6C ). In addition, analysis using an NF-κB reporter plasmid
(NF-κB–Luc) indicated that IκB-ζ dose-dependently inhibited Tax-
and RelA-induced NF-κB activation (Figure 6D). Furthermore, we
attempted to identify the domain(s) of IκB-ζ required to inhibit
Tax- and RelA-induced NF-κB activation. The deletion mutants of
IκB-ζ amino acids 1 to 456 and 457 to 728 did not inhibit Tax-
induced NF-κB activation. The deletion mutants of IκB-ζ amino
acids 1 to 456, 153 to 728, and 457 to 728 did not show any in-
hibition of RelA-induced NF-κB activation, whereas IκB-ζ amino
acids 188 to 728 exhibited moderate inhibition (Figure 6E ). These
results indicate that the N-terminal 187 amino acid and NLS are
not required for the inhibition of Tax- and RelA-induced NF-κB
activation, respectively.
Transcriptional induction of IL-8 and iNOS depends on coopera-
tive activities of NF-κB and AP-1 [52,55]. AP-1 also plays a role in
the viral transcription from the HTLV-I LTR [56]. IκB-ζ dose-
dependently inhibited Tax-induced AP-1 and HTLV-I LTR activation
(Figure 6, F and H). The deletion mutant of IκB-ζ amino acids 457
to 728 did not inhibit Tax-induced AP-1 activation, and the other
mutants similarly did not show inhibitory activity, although their
levels varied (Figure 6G ). These results suggest that the N-terminal
456 amino acid, and to a lesser extent the carboxyl-terminus, are
important for the inhibition of Tax-induced AP-1 activation. Taken
together, IκB-ζ exhibits dual roles in Tax-mediated transcription.
IκB-ζ Interacts with Tax
Finally, immunoprecipitation with anti-Tax Ab demonstrated
that IκB-ζ associated with Tax in 293T cells (Figure 7A). In addi-
tion, endogenous IκB-ζ associated with Tax in HUT-102 cells
(Figure 7B). GST pull-down assay by GST-Tax showed that IκB-ζ
physically interacted with Tax (Figure 7C ). WT IκB-ζ and the dele-
tion mutants of IκB-ζ amino acids 1 to 456, 153 to 728, and 188 to
728, but not the deletion mutant of IκB-ζ amino acids 457 to 728,
interacted with Tax (Figure 7D). These data suggest that N-terminal
IκB-ζ interacts with Tax.
Discussion
In this study, we showed Tax-dependent and Tax-independent IκB-ζ
gene expression in HTLV-I–infected T cell lines and ATL cells and
that such expression is NF-κB dependent. Our results are consistent
with oligonucleotide microarray data showing that IκB-ζ is one of
the genes that is upregulated more than 10-fold in three HTLV-I–
infected T cell lines compared with an uninfected T cell line [57].
Our results also demonstrated that Tax stimulation of the NF-κB
pathway is the primary route for IκB-ζ transcription, although
CREB phosphorylation also seemed to be involved in this process.
The promoter region, spanning positions −853 to −17, does not in-
clude CREB-binding sites. However, the Tax mutant 703 defective
for CREB activation, repressed IκB-ζ promoter activation, and the
disruption of CREB phosphorylation, by overexpressing CREB133,
partially inhibited the promoter activity in response to Tax. Collec-
tively, these findings indicate that although CREB phosphorylation
is not essential, it contributes to full IκB-ζ promoter activation.
Tax-negative ATL-derived T cell lines expressed low levels of
IκB-ζ mRNA and did not express the IκB-ζ protein compared with
Tax-positive transformed T cell lines. In EMSA using extracts from
ATL-derived T cell lines, oligonucleotide based on the IκB-ζ gene
κB1 site showed no detectable binding activity and that of the
κB2 site exhibited reduced binding activity compared with Tax-
positive T cell lines. Thus, a correlation was noted between IκB-ζ
expression levels and detection of NF-κB–binding activity. Fur-
thermore, activation of the IκB-ζ promoter induced by Tax was
almost eliminated by the deletion of the κB2 site. Taken together,
it is clear that the κB2 site is the major critical target for IκB-ζ
promoter activation.
In peripheral blood ATL cells, IκB-ζ mRNA levels did not correlate
with those of Tax mRNA. However, immunohistochemical staining
identified ATL cells positive for IκB-ζ in all lymph node samples
examined. Constitutive high NF-κB activity has been demonstrated
typically in ATL cells in which Tax expression is repressed in vivo
[6]. Thus, although NF-κB activation appears necessary for the con-
stitutive expression of IκB-ζ, transactivation by Tax is probably not
the only mechanism for overexpression of IκB-ζ in ATL cells.
IκB-ζ induced Bcl3 gene expression and enhanced Tax-dependent
Bcl3 gene induction. Previous studies showed that Tax induced Bcl3
in an NF-κB–dependent manner, and Bcl3 is constitutively expressed
in HTLV-I–infected T cells and ATL cells [50,51]. Bcl3 is an ankyrin
repeat–containing NF-κB–regulatory factor that is highly homologous
to IκB-ζ [7]. Enhanced Bcl3 expression leads to increased cell sur-
vival, proliferation, and malignant potential [58–60]. Bcl3 is also
implicated in the pathogenesis of many cancers commonly involving
coactivation of NF-κB p50 by Bcl3 as the transforming event [61–
64]. These reports and our study suggest that IκB-ζ may play an
important role in ATL genesis by inducing Bcl3 expression in HTLV-
I–infected T cells.
The N-terminal region of IκB-ζ interacted with Tax. In addition,
the TAD, NLS, and NF-κB–binding domains of IκB-ζ were re-
quired for Tax-dependent Bcl3 transactivation. These results indicate
that IκB-ζ–Tax interaction is important for enhancement of Tax-
dependent Bcl3 gene expression by IκB-ζ. Recently, the importance
of ubiquitination and sumoylation on Tax activation of NF-κB
has been investigated [65]. It is interesting whether posttransla-
tional modifications of Tax influence its interaction with IκB-ζ. Pre-
vious studies also showed that Bcl3 interacts with Tax, and this
interaction inhibits Tax-dependent HTLV-I LTR transactivation
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[50,66]. As shown in Figure 6H , IκB-ζ inhibited Tax-dependent LTR
transactivation. These findings suggest that IκB-ζ and Bcl3
cooperatively inhibit the Tax-dependent HTLV-I transcription and
viral replication in HTLV-I–infected T cells, resulting in facilitation
of immune evasion.
Tax plays a central role in T cell transformation, but hyperactivation
of Tax and NF-κB triggers cellular senescence and apoptotic responses
[67,68]. We found that IκB-ζ inhibited Tax-mediated NF-κB activa-
tion (Figure 6, D and E), resulting in repression of some Tax-induced
cellular gene expression. While these observations are seemingly
paradoxical, our results demonstrate the pleiotropic roles of IκB-ζ in
Tax-induced NF-κB activation and indicate that IκB-ζ can act to
counterbalance the aberrant Tax-mediated NF-κB hyperactivation
and, hence, may be established to play an important role in helping
maintain proliferation and promote the survival of HTLV-I–infected
T cells and ATL cells by preventing apoptosis.
Figure 6. IκB-ζmodulates Tax-induced gene transactivation. Jurkat cells were transfected with (A) pGL3–hIκB-ζ (−853), (B) IL-8 −133-Luc,
or (C) pGL3-iNOS together with the indicated amounts of empty vector or pcDNA3–FLAG–IκB-ζ in the absence or presence of pHβ-Tax.
The activities are expressed relative to that of cells transfected with each reporter plasmid and empty vector, which was defined as 1.
(D) Jurkat cells were transfected with NF-κB–Luc together with the indicated amounts of empty vector or pcDNA3–FLAG–IκB-ζ in the
absence or presence of pHβ-Tax (left) or pcDNA3-RelA (right). The activities are expressed relative to that of cells transfected with
NF-κB–Luc and empty vector, which was defined as 1. (E) Cells were transfected with NF-κB–Luc together with empty vector, pcDNA3–
FLAG–IκB-ζ, or its deletion mutants in the absence or presence of pHβ-Tax (left) or pcDNA3-RelA (right). The activities are expressed rela-
tive to that of cells transfected with NF-κB–Luc and empty vector, whichwas defined as 1. (F) Cells were transfected with AP-1–Luc together
with the indicated amounts of empty vector or pcDNA3–FLAG–IκB-ζ in the absence or presence of pHβ-Tax. The activities are expressed
relative to that of cells transfected with AP-1–Luc and empty vector, which was defined as 1. (G) Cells were transfected with AP-1–Luc
together with empty vector, pcDNA3–FLAG–IκB-ζ, or its deletion mutants in the absence or presence of pHβ-Tax. The activities are
expressed relative to that of cells transfected with AP-1–Luc and empty vector, which was defined as 1. (H) Cells were transfected with
HTLV-I LTR-Luc together with the indicated amounts of empty vector or pcDNA3–FLAG–IκB-ζ in the absence or presence of pHβ-Tax. Cells
were harvested 24 hours post-transfection, and luciferase activity was measured. The activities are expressed relative to that of cells trans-
fected with HTLV-I LTR–Luc and empty vector, which was defined as 1. The internal control reporter phRL-TK was cotransfected in all
experiments. Data are means ± SD of three independent transfection experiments.
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Figure 7. IκB-ζ interacts with Tax. (A) 293T cells were cotransfected with pcDNA3–FLAG–IκB-ζ and pHβ-Tax. Cells were harvested
24 hours post-transfection and lysed. WCEs were immunoprecipitated with anti-Tax Ab. Western blot analysis for FLAG–IκB-ζ and
Tax was performed by immunoblot analysis with anti-FLAG and anti-Tax Abs, respectively. (B) WCEs from HUT-102 cells were immuno-
precipitated with anti-Tax Ab, and Western blot analysis for IκB-ζ and Tax was performed by immunoblot analysis. (C) 293T cells were
transfected with empty vector (Mock) or pcDNA3–FLAG–IκB-ζ. Cells were harvested 24 hours post-transfection and lysed. WCEs were
mixed with glutathione sepharose 4B–conjugated GST (GST) or GST-Tax protein. The mixtures were incubated, washed, and eluted. The
eluted complexes were subjected to Western blot analysis using anti-FLAG Ab. GST and GST-Tax were detected by CBB staining.
(D) 293T cells were transfected with empty vector (Mock), pcDNA3–FLAG–WT IκB-ζ, or its deletion mutants. The lysates were incubated
with GST-Tax fusion protein, pulled down, and analyzed by Western blot analysis using anti-FLAG Ab. Expression of FLAG–WT IκB-ζ or
its deletion mutants were also performed by immunoblot analysis. GST-Tax was detected by CBB staining.
Figure 8. Pleiotropic roles of IκB-ζ in Tax-independent and Tax-dependent gene expression.
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Surprisingly, IκB-ζ induced several ISGs in T cells. IκB-ζ, but not
Tax, induced GBP-1 gene expression in an ISRE-dependent manner.
Consistent with our results, macrophages from IκB-ζ–deficient mice
exhibited impairment of GBP-1 gene expression in response to
lipopolysaccharide [69]. GBP-1 enhances epidermal growth factor
receptor–driven invasion in glioblastoma [70], and GBP-1 over-
expression is associated with the resistant phenotype to the anticancer
agent paclitaxel [71]. These findings suggest that induction of GBP-1
by IκB-ζ may be associated with malignant progression of ATL. In
addition, IκB-ζ and Tax induced the expression of a central mediator
of ISG expression, the STAT1 gene in T cells. Previous reports have
also shown that HTLV-I–transformed T cell lines and ATL cells
express high levels of STAT1, and Tax induces STAT1 gene expres-
sion in T cells [72,73]. However, the role of this STAT1/ISG axis in
leukemogenesis remains to be clarified.
Figure 8 summarizes the findings of this study. In this model,
IκB-ζ can bind to and modulate Tax function. IκB-ζ inhibits Tax-
dependent IκB-ζ and IL-8 transactivation, whereas it induces and
enhances Bcl3 and iNOS transactivation together with Tax in
an NF-κB–dependent manner. Thus, IκB-ζ exhibits dual roles in
NF-κB–mediated transcription in the presence of Tax, although the
mechanism that determines the opposing actions of IκB-ζ on different
genes remains to be defined. In addition to NF-κB–binding sites,
another element may be required for the IκB-ζ–mediated transcrip-
tional activation [74], because IκB-ζ acts as a negative regulator on
the promoter harboring five repeats of NF-κB sequences (NF-κB–
Luc [36]). IκB-ζ mutant, 188 to 728, deleted N-terminal 187 amino
acid, failed to enhance Tax-induced Bcl3 transcription but inhibited
Tax-induced NF-κB activation, suggesting that N-terminal 187 amino
acid is important for enhancement of Tax-induced NF-κB activation
but not required for inhibition of Tax-induced NF-κB activation. This
region also interacts with Tax. IκB-ζ inhibited the activation of NF-κB
by Tax and RelA. Similarly, the pleiotropic roles of Bcl3 in Tax-
induced NF-κB activation have been recently reported [75]. In addi-
tion, IκB-ζ inhibited Tax-induced AP-1 and HTLV-I LTR activation.
Tax induces IκB-ζ overexpression by activating the NF-κB pathway,
and the elevated IκB-ζ might lead to increased cell proliferation, cell
survival, and malignant potential by inducing expression of Bcl3,
iNOS, GBP-1, and so on. We found that IκB-ζ negatively modulates
Tax-induced NF-κB, AP-1, and HTLV-I LTR activation. It is likely
that the Tax–IκB-ζ interaction at protein and gene expression levels
results in a fine balance that ultimately endows a net evolutionary
benefit to the survival of viral infected T cells. Furthermore, IκB-ζ
may contribute to the pathogenesis of ATL, in which leukemic cells
do not express Tax protein, through the up-regulation of NF-κB–
regulated genes and ISGs.
Acknowledgments
We express our gratitude to T. Muta, Y. Saitoh, and S. Yamaoka for
providing expression vectors for IκB-ζ and its mutants, reporter plas-
mids for IκB-ζ, and a lentiviral vector pCS-puro-PRE. We also thank
K.Matsumoto,M. DucDodon, L. Larue, D.W. Ballard, R. Geleziunas,
K.-T. Jeang, M. Stürzl, T. W. McKeithan, N. Mukaida, T. K. Nowling,
J. Fujisawa, I. Futsuki, and Y. Tanaka for providing expression vectors
for Tax and its mutants, for HBZ, for RelA, for IκBα- and IκBβ-
dominant negative mutants, for NIK-, IKK1-, and IKK2-dominant
negative mutants, for NEMO-dominant negative mutant, for provid-
ing reporter plasmids for GBP-1, for Bcl3, for IL-8 and AP-1, for
iNOS, for NF-κB, for HTLV-I LTR, and for providing Tax Ab. We
acknowledge H. Miyoshi for providing CS-CDF-CG-PRE, pCAG-
HIVgp, and pCMV-VSV-G-RSV-Rev plasmids. We also thank
M. Nakamura for providing JPX-9, M. Maeda for providing ED-
40515(−), and Fujisaki Cell Center, Hayashibara Biomedical Labora-
tories for providing HUT-102, C5/MJ, and MT-1.
References
[1] Yoshida M, Miyoshi I, and Hinuma Y (1982). Isolation and characterization of
retrovirus from cell lines of human adult T-cell leukemia and its implication in
the disease. Proc Natl Acad Sci USA 79, 2031–2035.
[2] Watanabe T (1997). HTLV-1-associated diseases. Int J Hematol 66, 257–278.
[3] Matsuoka M and Jeang KT (2007). Human T-cell leukaemia virus type 1
(HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7, 270–280.
[4] Grassmann R, Aboud M, and Jeang KT (2005). Molecular mechanisms of
cellular transformation by HTLV-1 Tax. Oncogene 24, 5976–5985.
[5] Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T, and
Hatanaka M (1996). Constitutive activation of NF-κB is essential for transforma-
tion of rat fibroblasts by the human T-cell leukemia virus type I Tax protein.
EMBO J 15, 873–887.
[6] Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, and
Yamamoto N (1999). Constitutive activation of NF-κB in primary adult T-cell
leukemia cells. Blood 93, 2360–2368.
[7] Muta T (2006). IκB-ζ: an inducible regulator of nuclear factor-κB. Vitam Horm
74, 301–316.
[8] Kitamura H, Kanehira K, Okita K, Morimatsu M, and Saito M (2000). MAIL,
a novel nuclear IκB protein that potentiates LPS-induced IL-6 production.
FEBS Lett 485, 53–56.
[9] Haruta H, Kato A, and Todokoro K (2001). Isolation of a novel interleukin-
1-inducible nuclear protein bearing ankyrin-repeat motifs. J Biol Chem 276,
12485–12488.
[10] Yamazaki S, Muta T, Matsuo S, and Takeshige K (2005). Stimulus-specific
induction of a novel nuclear factor-κB regulator, IκB-ζ, via Toll/interleukin-1
receptor is mediated by mRNA stabilization. J Biol Chem 280, 1678–1687.
[11] Ito T, Morimatsu M, Oonuma T, Shiina T, Kitamura H, and Syuto B (2004).
Transcriptional regulation of the MAIL gene in LPS-stimulated RAW264
mouse macrophages. Gene 342, 137–143.
[12] Yamazaki S, Muta T, and Takeshige K (2001). A novel IκB protein, IκB-ζ,
induced by proinflammatory stimuli, negatively regulates nuclear factor-κB in
the nuclei. J Biol Chem 276, 27657–27662.
[13] Motoyama M, Yamazaki S, Eto-Kimura A, Takeshige K, and Muta T (2005).
Positive and negative regulation of nuclear factor-κB-mediated transcription by
IκB-ζ, an inducible nuclear protein. J Biol Chem 280, 7444–7451.
[14] Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, and Hinuma Y
(1989). Electroporation: application to human lymphoid cell lines for stable
introduction of a transactivator gene of human T-cell leukemia virus type I.
Nucleic Acids Res 17, 1589–1604.
[15] Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata
K, and Hinuma Y (1981). Type C virus particles in a cord T-cell line derived
by co-cultivating normal human cord leukocytes and human leukaemic T cells.
Nature 294, 770–771.
[16] Yamamoto N, Okada M, Koyanagi Y, Kannagi M, and Hinuma Y (1982).
Transformation of human leukocytes by cocultivation with an adult T cell
leukemia virus producer cell line. Science 217, 737–739.
[17] Popovic M, Sarin PS, Robert-Gurroff M, Kalyanaraman VS, Mann D,
Minowada J, and Gallo RC (1983). Isolation and transmission of human retro-
virus (human T-cell leukemia virus). Science 219, 856–859.
[18] Koeffler HP, Chen IS, and Golde DW (1984). Characterization of a novel
HTLV-infected cell line. Blood 64, 482–490.
[19] Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, and
Guccion JG (1980). Mitogen requirements for the in vitro propagation of
cutaneous T-cell lymphomas. Blood 55, 409–417.
[20] Miyoshi I, Kubonishi I, Sumida M, Hiraki S, Tsubota T, Kimura I, Miyamoto
K, and Sato J (1980). A novel T-cell line derived from adult T-cell leukemia.
Gann 71, 155–156.
[21] Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, and Hinuma Y
(1984). Cell surface phenotypes and expression of viral antigens of various human
cell lines carrying human T-cell leukemia virus. Int J Cancer 34, 221–228.
[22] Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T, Honjo
T, and Yodoi J (1985). Origin of human T-lymphotrophic virus I–positive T cell
1122 IκB-ζ Modulates Gene Expression in T Cells Kimura et al. Neoplasia Vol. 15, No. 9, 2013
lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement.
J Exp Med 162, 2169–2174.
[23] Tanaka Y, Yoshida A, Takayama Y, Tsujimoto H, Tsujimoto A, Hayami M,
and Tozawa H (1990). Heterogeneity of antigen molecules recognized by
anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia
virus type I and related retroviruses. Jpn J Cancer Res 81, 225–231.
[24] Kimura R, Ishikawa C, Rokkaku T, Janknecht R, and Mori N (2011). Phos-
phorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby
regulate invasion activity of 143B osteosarcoma cells. Biochim Biophys Acta 1813,
1543–1553.
[25] Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, and Yoshie O
(2008). Tax-inducible production of CC chemokine ligand 22 by human
T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential
transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol 180,
931–939.
[26] Hughes-Fulford M, Sugano E, Schopper T, Li CF, Boonyaratanakornkit JB,
and Cogoli A (2005). Early immune response and regulation of IL-2 receptor
subunits. Cell Signal 17, 1111–1124.
[27] Elliott SF, Coon CI, Hays E, Stadheim TA, and Vincenti MP (2002). Bcl-3 is
an interleukin-1–responsive gene in chondrocytes and synovial fibroblasts that
activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum
46, 3230–3239.
[28] Mirpuri J, Brazil JC, Berardinelli AJ, Nasr TR, Cooper K, Schnoor M, Lin PW,
Parkos CA, and Louis NA (2010). Commensal Escherichia coli reduces epi-
thelial apoptosis through IFN-αA–mediated induction of guanylate binding
protein-1 in human and murine models of developing intestine. J Immunol 184,
7186–7195.
[29] Wood VH, O’Neil JD, Wei W, Stewart SE, Dawson CW, and Young LS
(2007). Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcrip-
tion and modulates the STAT1 and TGFβ signaling pathways. Oncogene 26,
4135–4147.
[30] Lee JK, Boles KS, and Mathew PA (2004). Molecular and functional charac-
terization of a CS1 (CRACC) splice variant expressed in human NK cells that
does not contain immunoreceptor tyrosine-based switch motifs. Eur J Immunol
34, 2791–2799.
[31] Ge B, Li O, Wilder P, Rizzino A, and McKeithan TW (2003). NF-κB regulates
BCL3 transcription in T lymphocytes through an intronic enhancer. J Immunol
171, 4210–4218.
[32] Naschberger E, Werner T, Vicente AB, Guenzi E, Töpolt K, Leubert R, Lubeseder-
Martellato C, Nelson PJ, and Stürzl M (2004). Nuclear factor-κB motif and
interferon-α-stimulated response element co-operate in the activation of guanylate-
binding protein-1 expression by inflammatory cytokines in endothelial cells.
Biochem J 379, 409–420.
[33] Amalraj J, Cutler SJ, Ghazawi I, Boyle GM, and Ralph SJ (2013). REST nega-
tively and ISGF3 positively regulate the human STAT1 gene in melanoma.
Mol Cancer Ther 12, 1288–1298.
[34] Okamoto S, Mukaida N, Yasumoto K, Rice N, Ishikawa Y, Horiguchi H,
Murakami S, and Matsushima K (1994). The interleukin-8 AP-1 and κB-like
sites are genetic end targets of FK506-sensitive pathway accompanied by calcium
mobilization. J Biol Chem 269, 8582–8589.
[35] Crosby MB, Svenson J, Gilkeson GS, and Nowling TK (2005). A novel
PPAR response element in the murine iNOS promoter. Mol Immunol 42,
1303–1310.
[36] Suzuki T, Hirai H, Murakami T, and Yoshida M (1995). Tax protein of
HTLV-1 destabilizes the complexes of NF-κB and I κB-α and induces
nuclear translocation of NF-κB for transcriptional activation. Oncogene 10,
1199–1207.
[37] Ohtani K, Nakamura M, Saito S, Noda T, Ito Y, Sugamura K, and Hinuma Y
(1987). Identification of two distinct elements in the long terminal repeat of
HTLV-I responsible for maximum gene expression. EMBO J 6, 389–395.
[38] Matsumoto K, Shibata H, Fujisawa JI, Inoue H, Hakura A, Tsukahara T, and
Fujii M (1997). Human T-cell leukemia virus type 1 Tax protein transforms rat
fibroblasts via two distinct pathways. J Virol 71, 4445–4451.
[39] Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, and
Ballard DW (1995). Coupling of a signal response domain in IκBα to multiple
pathways for NF-κB activation. Mol Cell Biol 15, 2809–2818.
[40] McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, and
Ballard DW (1996). Inactivation of IκBβ by the tax protein of human T-cell
leukemia virus type 1: a potential mechanism for constitutive induction of
NF-κB. Mol Cell Biol 16, 2083–2090.
[41] Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly
MA, Hambor JE, Marcu KB, and Greene WC (1998). Human T-cell leukemia
virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α
(IKKα) and IKKβ cellular kinases. Mol Cell Biol 18, 5157–5165.
[42] Iha H, Kibler KV, Yedavalli VR, Peloponese JM, Haller K, Miyazato A, Kasai
T, and Jeang KT (2003). Segregation of NF-κB activation through NEMO/
IKKγ by Tax and TNFα: implications for stimulus-specific interruption of
oncogenic signaling. Oncogene 22, 8912–8923.
[43] Kuhlmann AS, Villaudy J, Gazzolo L, Castellazzi M, Mesnard JM, and Duc
Dodon M (2007). HTLV-1 HBZ cooperates with JunD to enhance transcrip-
tion of the human telomerase reverse transcriptase gene (hTERT). Retrovirology
4, 92.
[44] Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C,
de Herreros AG, Bellacosa A, and Larue L (2007). Activation of NF-κB by Akt
upregulates Snail expression and induces epithelium mesenchyme transition.
Oncogene 26, 7445–7456.
[45] Saitoh Y, Yamamoto N, Dewan MZ, Sugimoto H, Martinez Bruyn VJ, Iwasaki
Y, Matsubara K, Qi X, Saitoh T, Imoto I, et al. (2008). Overexpressed NF-κB–
inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and
Hodgkin Reed-Sternberg cells. Blood 111, 5118–5129.
[46] Fu J, Yan P, Li S, Qu Z, and Xiao G (2010). Molecular determinants of
PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis. Oncogene 29,
6499–6507.
[47] Amorino GP, Mikkelsen RB, Valerie K, and Schmidt-Ullrich RK (2003).
Dominant-negative cAMP-responsive element-binding protein inhibits pro-
liferating cell nuclear antigen and DNA repair, leading to increased cellular
radiosensitivity. J Biol Chem 278, 29394–29399.
[48] Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, and
Gerritsen ME (1997). Novel inhibitors of cytokine-induced IκBα phosphoryla-
tion and endothelial cell adhesion molecule expression show anti-inflammatory
effects in vivo. J Biol Chem 272, 21096–21103.
[49] Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, and Debatin KM (1998).
Inhibition of nuclear factor κB activation attenuates apoptosis resistance in
lymphoid cells. Blood 91, 4624–4631.
[50] Kim YM, Sharma N, and Nyborg JK (2008). The proto-oncogene Bcl3,
induced by Tax, represses Tax-mediated transcription via p300 displacement from
the human T-cell leukemia virus type 1 promoter. J Virol 82, 11939–11947.
[51] Ishikawa C, Nakachi S, Senba M, Sugai M, and Mori N (2011). Activation of
AID by human T-cell leukemia virus Tax oncoprotein and the possible role of
its constitutive expression in ATL genesis. Carcinogenesis 32, 110–119.
[52] Mori N, Mukaida N, Ballard DW, Matsushima K, and Yamamoto N (1998).
Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene
through acting concurrently on AP-1 and nuclear factor-κB-like sites. Cancer Res
58, 3993–4000.
[53] Xie Q-W, Kashiwabara Y, and Nathan C (1994). Role of transcription factor
NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 269, 4705–4708.
[54] Goto H, Nakamura T, Shirabe S, Ueki Y, Nishiura Y, Furuya T, Tsujino A,
Nakane S, Eguchi K, and Nagataki S (1997). Up-regulation of iNOS mRNA
expression and increased production of NO in human monoblast cell line,
U937 transfected by HTLV-I tax gene. Immunobiology 197, 513–521.
[55] Marks-Konczalik J, Chu SC, and Moss J (1998). Cytokine-mediated transcrip-
tional induction of the human inducible nitric oxide synthase gene requires
both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem 273,
22201–22208.
[56] Jeang KT, Chiu R, Santos E, and Kim SJ (1991). Induction of the HTLV-I
LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology 181,
218–227.
[57] Baba M, Okamoto M, Hamasaki T, Horai S, Wang X, Ito Y, Suda Y, and Arima
N (2008). Highly enhanced expression of CD70 on human T-lymphotropic
virus type 1-carrying T-cell lines and adult T-cell leukemia cells. J Virol 82,
3843–3852.
[58] Courtois G and Gilmore TD (2006). Mutations in the NF-κB signaling
pathway: implications for human disease. Oncogene 25, 6831–6843.
[59] McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK,
Dubé I, Sandberg AA, and Rowley JD (1997). BCL3 rearrangements and
t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies:
a molecular and cytogenetic study. Genes Chromosomes Cancer 20, 64–72.
[60] Ohno H, Takimoto G, and McKeithan TW (1990). The candidate proto-
oncogene bcl-3 is related to genes implicated in cell lineage determination
and cell cycle control. Cell 60, 991–997.
Neoplasia Vol. 15, No. 9, 2013 IκB-ζ Modulates Gene Expression in T Cells Kimura et al. 1123
[61] Fujita T, Nolan GP, Liou HC, Scott ML, and Baltimore D (1993). The
candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that acti-
vates through NF-κB p50 homodimers. Genes Dev 7, 1354–1363.
[62] Cogswell PC, Guttridge DC, Funkhouser WK, and Baldwin AS Jr (2000).
Selective activation of NF-κB subunits in human breast cancer: potential roles
for NF-κB2/p52 and for Bcl-3. Oncogene 19, 1123–1131.
[63] Thornburg NJ, Pathmanathan R, and Raab-Traub N (2003). Activation of
nuclear factor-κB p50 homodimer/Bcl-3 complexes in nasopharyngeal carci-
noma. Cancer Res 63, 8293–8301.
[64] Mathas S, Jöhrens K, Joos S, Lietz A, Hummel F, Janz M, Jundt F,
Anagnostopoulos I, Bommert K, Lichter P, et al. (2005). Elevated NF-κB p50
complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-
cell, and other peripheral T-cell lymphomas. Blood 106, 4287–4293.
[65] Zane L and Jeang K-T (2012). The importance of ubiquitination and sumoylation
on the transforming activity of HTLV Tax-1 and Tax-2. Retrovirology 9, 103.
[66] Hishiki T, Ohshima T, Ego T, and Shimotohno K (2007). BCL3 acts as a nega-
tive regulator of transcription from the human T-cell leukemia virus type 1 long ter-
minal repeat through interactions with TORC3. J Biol Chem 282, 28335–28343.
[67] Ho YK, Zhi H, DeBiaso D, Philip S, Shih HM, and Giam CZ (2012).
HTLV-1 tax-induced rapid senescence is driven by the transcriptional activity
of NF-κB and depends on chronically activated IKKα and p65/RelA. J Virol
86, 9474–9483.
[68] Chlichlia K and Khazaie K (2010). HTLV-1 Tax: linking transformation, DNA
damage and apoptotic T-cell death. Chem Biol Interact 188, 359–365.
[69] Yamamoto M, Yamazaki S, Uematsu S, Sato S, Hemmi H, Hoshino K, Kaisho
T, Kuwata H, Takeuchi O, Takeshige K, et al. (2004). Regulation of Toll/IL-1-
receptor-mediated gene expression by the inducible nuclear protein IκBζ.
Nature 430, 218–222.
[70] Li M, Mukasa A, Inda MM, Zhang J, Chin L, Cavenee W, and Furnari F
(2011). Guanylate binding protein 1 is a novel effector of EGFR-driven
invasion in glioblastoma. J Exp Med 208, 2657–2673.
[71] Duan Z, Foster R, Brakora KA, Yusuf RZ, and Seiden MV (2006). GBP1 over-
expression is associated with a paclitaxel resistance phenotype. Cancer Chemother
Pharmacol 57, 25–33.
[72] Nakamura N, Fujii M, Tsukahara T, Arai M, Ohashi T, Wakao H, Kannagi M,
and Yamamoto N (1999). Human T-cell leukemia virus type 1 Tax protein
induces the expression of STAT1 and STAT5 genes in T-cells. Oncogene 18,
2667–2675.
[73] Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, Hidaka T, Kubuki Y,
Okayama A, Hamada K, Okabe H, et al. (2005). Overexpression of a cell
adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult
T-cell leukemia. Blood 105, 1204–1213.
[74] Matsuo S, Yamazaki S, Takeshige K, and Muta T (2007). Crucial roles of
binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activa-
tion. Biochem J 405, 605–615.
[75] Wang J, Li J, Huang Y, Song X, Niu Z, Gao Z, and Wang H (2013). Bcl-3
suppresses Tax-induced NF-κB activation through p65 nuclear translocation
blockage in HTLV-1-infected cells. Int J Oncol 42, 269–276.
1124 IκB-ζ Modulates Gene Expression in T Cells Kimura et al. Neoplasia Vol. 15, No. 9, 2013
